| Dr Mark Thomas Foehr, MD | |
|
69 West Main St, Bay Shore, NY 11706 | |
| (631) 665-4044 | |
| (631) 665-3928 |
| Full Name | Dr Mark Thomas Foehr |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 69 West Main St, Bay Shore, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144307299 | NPI | - | NPPES |
| 01569295 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 182878 (New York) | Primary |
| Entity Name | Good Samaritan Hospital Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518901180 PECOS PAC ID: 5294639951 Enrollment ID: O20031124000491 |
News Archive
Breast cancer, in the stage with distant metastases, is an incurable disease with a 5 years survival rate of about 5-10%. Immunotherapy has recently improved survival in metastatic breast cancer patients with breast cancer harboring the expression of HER 2 receptor.
A 43-year old mum of one from Bristol, who suffered from frequent painful migraines for almost a decade has found relief thanks to BetterYou™ Magnesium Oil spray.
PlanSource, a cloud-based, on-demand technology company that provides state-of-the-art benefits administration, exchange, payroll, and HRIS solutions to employers through insurance carriers and brokers, has announced that it is expanding its strategic relationship with Aetna into three new states: Georgia, North Carolina, and Tennessee.
Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. The milestone was triggered by Agensys' initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics' technology.
A new optical imaging system which uses infrared light has shown promise in predicting early responses to chemotherapy in breast cancer patients.
› Verified 9 days ago
| Entity Name | Sun River Health Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568526838 PECOS PAC ID: 6608783568 Enrollment ID: O20040714000375 |
News Archive
Breast cancer, in the stage with distant metastases, is an incurable disease with a 5 years survival rate of about 5-10%. Immunotherapy has recently improved survival in metastatic breast cancer patients with breast cancer harboring the expression of HER 2 receptor.
A 43-year old mum of one from Bristol, who suffered from frequent painful migraines for almost a decade has found relief thanks to BetterYou™ Magnesium Oil spray.
PlanSource, a cloud-based, on-demand technology company that provides state-of-the-art benefits administration, exchange, payroll, and HRIS solutions to employers through insurance carriers and brokers, has announced that it is expanding its strategic relationship with Aetna into three new states: Georgia, North Carolina, and Tennessee.
Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. The milestone was triggered by Agensys' initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics' technology.
A new optical imaging system which uses infrared light has shown promise in predicting early responses to chemotherapy in breast cancer patients.
› Verified 9 days ago
| Entity Name | Samaritan Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124184544 PECOS PAC ID: 7012016009 Enrollment ID: O20070727000051 |
News Archive
Breast cancer, in the stage with distant metastases, is an incurable disease with a 5 years survival rate of about 5-10%. Immunotherapy has recently improved survival in metastatic breast cancer patients with breast cancer harboring the expression of HER 2 receptor.
A 43-year old mum of one from Bristol, who suffered from frequent painful migraines for almost a decade has found relief thanks to BetterYou™ Magnesium Oil spray.
PlanSource, a cloud-based, on-demand technology company that provides state-of-the-art benefits administration, exchange, payroll, and HRIS solutions to employers through insurance carriers and brokers, has announced that it is expanding its strategic relationship with Aetna into three new states: Georgia, North Carolina, and Tennessee.
Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. The milestone was triggered by Agensys' initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics' technology.
A new optical imaging system which uses infrared light has shown promise in predicting early responses to chemotherapy in breast cancer patients.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Thomas Foehr, MD 69 West Main St, Bay Shore, NY 11706 Ph: (631) 665-4044 | Dr Mark Thomas Foehr, MD 69 West Main St, Bay Shore, NY 11706 Ph: (631) 665-4044 |
News Archive
Breast cancer, in the stage with distant metastases, is an incurable disease with a 5 years survival rate of about 5-10%. Immunotherapy has recently improved survival in metastatic breast cancer patients with breast cancer harboring the expression of HER 2 receptor.
A 43-year old mum of one from Bristol, who suffered from frequent painful migraines for almost a decade has found relief thanks to BetterYou™ Magnesium Oil spray.
PlanSource, a cloud-based, on-demand technology company that provides state-of-the-art benefits administration, exchange, payroll, and HRIS solutions to employers through insurance carriers and brokers, has announced that it is expanding its strategic relationship with Aetna into three new states: Georgia, North Carolina, and Tennessee.
Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. The milestone was triggered by Agensys' initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics' technology.
A new optical imaging system which uses infrared light has shown promise in predicting early responses to chemotherapy in breast cancer patients.
› Verified 9 days ago
William Chukwukeziri Onyebeke, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 46 Brentwood Rd, Bay Shore, NY 11706 Phone: 631-206-1384 Fax: 631-206-1436 | |
Peter S. Finamore, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 376 East Main St, Suite 201, Bay Shore, NY 11706 Phone: 516-663-3010 Fax: 516-663-3026 | |
Katherine Rimpel, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 370 E Main St Ste 5, Bay Shore, NY 11706 Phone: 631-968-3322 | |
Dr. Matthew J. Blitz, M.D., M.B.A. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 376 E Main St Ste 202, Bay Shore, NY 11706 Phone: 631-396-7000 Fax: 631-396-7026 | |
Cara Wetcher, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 376 E Main St Ste 202, Bay Shore, NY 11706 Phone: 631-396-7000 | |
Dr. Sharon Ruth Gerber, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 376 E Main St Ste 202, Bay Shore, NY 11706 Phone: 631-396-7000 Fax: 631-396-7026 |